Eric P. Winer
0000-0002-8819-1723
Publication & Citation Trends
Publications
0 total
Abstract PS3-11-04: Adjuvant Ado-Trastuzumab Emtansine (T-DM1) for Older Patients with HER2+ Breast Cancer - Results from the ATOP Study
Cited by 0
Semantic Scholar
Abstract RF7-07: Adjuvant Palbociclib for ER+ Breast Cancer in the PALLAS Trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13): Post-Recurrence Treatment and Overall Survival
Cited by 0
Semantic Scholar
TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA1 or BRCA2.
Cited by 0
Semantic Scholar
Abstract PS5-08-07: Open-label Single-arm Phase 2 Trial of Trastuzumab Deruxtecan in Previously Treated HER2-Immunohistochemistry (IHC) 0 Advanced Breast Cancer - HER2 PARADIGM trial
Cited by 0
Semantic Scholar
Abstract RF4-01: Central Nervous System Outcomes from the Phase III PATINA Trial (AFT-38)
Cited by 0
Semantic Scholar
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.
Cited by 2
Semantic Scholar
Abstract GS1-04: Tumor infiltrating lymphocytes (TILs) and pathologic complete response (pCR) in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): secondary results from the ECOG-ACRIN EA1181/CompassHER2 pCR trial
Cited by 0
Semantic Scholar
Abstract PS4-07-18: Association of tumor-infiltrating lymphocytes (TILs) with outcomes in patients with early TNBC treated with neoadjuvant chemotherapy with or without pembrolizumab
Cited by 0
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(521)
Advanced Breast Cancer Therapies
(458)
HER2/EGFR in Cancer Research
(422)
Cancer Treatment and Pharmacology
(404)
Cancer Genomics and Diagnostics
(223)
Affiliations
Brighton and Sussex Medical School
New School
Pennington Biomedical Research Center
Broad Institute
Boston University